Residency · Residency · Allergy Immunology

Occupational Allergy and Asthma

Overview

Occupational asthma (OA) is asthma caused directly by workplace exposures and accounts for an estimated 15 to 25% of all adult-onset asthma, making it one of the most prevalent occupational lung diseases in industrialized countries. It is critical to distinguish occupational asthma from work-exacerbated asthma (WEA), in which pre-existing asthma is worsened by workplace exposures but was not caused by them, as the clinical, medicolegal, and prognostic implications differ substantially. Occupational rhinitis frequently precedes the development of occupational asthma by months to years, with approximately 50% of OA patients reporting antecedent rhinitis symptoms, highlighting the importance of screening for lower airway disease in workers presenting with occupational rhinitis. Early diagnosis and prompt removal from the causative exposure is the most critical determinant of long-term outcome, as delayed removal leads to persistent asthma even after exposure ceases. The economic burden of occupational asthma encompasses lost productivity, disability, workers' compensation claims, and ongoing healthcare costs.

Classification

Sensitizer-Induced OA (Immunologic OA)

Sensitizer-induced occupational asthma is the most common form, accounting for approximately 90% of all cases. It is defined by the requirement for a latency period -- a window of exposure lasting weeks to years -- during which immunologic sensitization develops before the onset of asthma symptoms. This latency period is a key clinical feature that distinguishes immunologic OA from irritant-induced forms.

Sensitizer-induced OA is further subclassified based on the molecular weight of the causative agent and the mechanism of sensitization. High-molecular-weight (HMW) agents, generally exceeding 5 kilodaltons, are complete antigens that typically elicit IgE-mediated immune responses. These include proteins derived from biological sources such as flour, animal dander, latex, and enzymes. Low-molecular-weight (LMW) agents function as haptens that must conjugate with endogenous proteins to become immunogenic. The immune mechanisms underlying LMW agent-induced OA are less well characterized and may involve a combination of Th1, Th2, and T cell-mediated pathways; specific IgE is detectable in only a subset of affected patients.

Irritant-Induced OA

Irritant-induced occupational asthma occurs without a latency period and without immunologic sensitization. The prototypical form is reactive airways dysfunction syndrome (RADS), which develops acutely within 24 hours of a single high-level exposure to a respiratory irritant in an individual with no prior history of asthma. RADS is characterized by persistent bronchial hyperresponsiveness and airflow obstruction that may last for years following the inciting event. A more controversial entity is low-dose irritant-induced OA, in which repeated exposures to low levels of irritants over time gradually produce airway inflammation and eventual asthma, though the evidence base for this entity remains limited.

Common Occupational Sensitizers

Common Occupational Sensitizers by Type

High-Molecular-Weight (HMW) Agents

Flour and grain dust represent one of the oldest recognized occupational hazards, causing baker's asthma in bakers and grain handlers through sensitization to wheat allergens including Tri a 14 (a lipid transfer protein) and alpha-amylase inhibitors. Laboratory animal allergens, particularly Rat n 1 (a major urinary protein from rats) and Mus m 1 (from mice), affect researchers, veterinary staff, and animal facility workers. Natural rubber latex was historically a major cause of occupational asthma in healthcare workers and rubber industry employees, though its prevalence has decreased substantially with the widespread adoption of non-latex glove policies. Biological enzymes, including subtilisins used in the detergent industry and amylase and papain used in food processing, are potent occupational sensitizers. Seafood processing workers may develop sensitization to shrimp, crab, and fish proteins through inhalational exposure during handling and processing.

Low-Molecular-Weight (LMW) Agents

Diisocyanates, including toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), and hexamethylene diisocyanate (HDI), are the most common cause of occupational asthma in many countries. They are encountered in spray painting, polyurethane foam production, and adhesive manufacturing. Diisocyanates can elicit both immediate and late-phase bronchial responses, and specific IgE is detectable in only 20 to 50% of affected workers, indicating that non-IgE mechanisms play a significant role. Anhydrides, including trimellitic anhydride (TMA) and phthalic anhydride, are used in plastics and epoxy resin production and can cause not only occupational asthma but also hypersensitivity pneumonitis and, in the case of TMA, a distinctive pulmonary disease-anemia syndrome.

Persulfates are among the most common causes of OA in the cosmetology industry, affecting hairdressers who use these compounds in hair bleaching products. Metal exposures include platinum salts (chloroplatinate), which characteristically produce IgE-mediated sensitization, and chromium, nickel, and cobalt, which typically cause non-IgE-mediated disease. Aldehydes, specifically formaldehyde and glutaraldehyde, affect healthcare workers and laboratory personnel. Pharmaceutical workers and nurses may develop sensitization to drug dusts, including penicillins, cephalosporins, and psyllium. Acrylates, including cyanoacrylates and methacrylates, are occupational hazards for dental professionals and nail technicians.

<image>An illustrated occupational exposure map organized by industry/profession and associated sensitizing agents. Central hub labeled "Occupational Asthma Sensitizers." Radiating outward to industry sectors: (1) Healthcare: latex, glutaraldehyde, methacrylates, formaldehyde, drug dusts. (2) Bakery/Food processing: flour, enzymes (alpha-amylase), seafood proteins. (3) Automotive/Paint: diisocyanates (TDI, MDI, HDI) with spray painting illustration. (4) Hairdressing: persulfates, hair dyes (PPD). (5) Laboratory/Animal facility: rat/mouse allergens (Rat n 1, Mus m 1). (6) Woodworking: western red cedar (plicatic acid), exotic hardwoods. (7) Cleaning/Detergent: enzymes (subtilisins), chlorine-based products. (8) Agriculture: grain dust, animal dander, pesticides. Each sector shows: agent type (HMW vs LMW), mechanism (IgE vs non-IgE), and exposure route. Color-coded by mechanism: green for IgE-mediated HMW, orange for non-IgE LMW, red for irritant.</image>

Diagnosis

Clinical History

The clinical history must establish a temporal relationship between workplace exposure and asthma symptoms. Patients typically describe symptoms that worsen during work exposure and improve during weekends, vacations, or job changes. The presence of a latency interval between initial occupational exposure and symptom onset favors sensitizer-induced over irritant-induced OA. A thorough exposure assessment should identify the specific agents encountered, their concentrations, the duration of exposure, and the use of protective equipment. It is essential to determine whether asthma existed before the occupational exposure, as this distinction separates true occupational asthma from work-exacerbated asthma. Documentation of smoking history, atopic status, and pre-existing rhinitis or asthma is important for both clinical and medicolegal purposes.

Physiologic Testing

Serial Peak Flow Monitoring

Serial peak expiratory flow (PEF) monitoring is the most practical and widely validated tool for establishing the work-relatedness of asthma. Patients are instructed to perform PEF measurements every two hours while awake for a minimum of two weeks during active work exposure and two weeks while away from work. The OASYS software system provides validated analysis of serial PEF data, with a reported sensitivity of approximately 75% and specificity of approximately 94% for occupational asthma. A minimum of four readings per day is recommended, though patient compliance remains a significant limitation. Documentation of greater than 20% diurnal PEF variability during work periods compared to less than 20% variability during periods away from work supports the diagnosis.

Specific Inhalation Challenge (SIC)

Specific inhalation challenge remains the gold standard for diagnosing occupational asthma. In this test, the patient is exposed in a controlled laboratory chamber to the suspected occupational agent under carefully monitored conditions. Serial FEV1 measurements are performed for at least eight hours post-exposure to detect both immediate responses (occurring within 30 minutes) and late-phase responses (occurring at 4 to 8 hours). Response patterns may be classified as immediate, late, dual (both), or atypical. SIC is available only in specialized centers and is labor-intensive to perform. False-negative results may occur if the patient has been away from the occupational exposure for an extended period, as bronchial responsiveness to the specific agent may wane.

Methacholine Challenge

Methacholine challenge testing demonstrates increased bronchial hyperresponsiveness, supporting the diagnosis of asthma. In the context of occupational asthma evaluation, the provocative concentration of methacholine causing a 20% fall in FEV1 (PC20) may normalize if the patient has been away from the causative exposure for an extended period. Performing methacholine challenges both before and after a period of return to work can demonstrate worsening bronchial hyperresponsiveness (a decreasing PC20) that supports the diagnosis of OA.

Immunologic Testing

Skin prick testing is available for some HMW occupational allergens, including flour, latex, laboratory animal proteins, and biological enzymes, and a positive result documents IgE-mediated sensitization. Serum-specific IgE via ImmunoCAP is available for selected occupational allergens. For LMW agents such as isocyanates, specific IgE testing has limited sensitivity (approximately 20 to 50%), and a negative result emphatically does not exclude occupational asthma. Precipitins (specific IgG) are used for evaluating hypersensitivity pneumonitis rather than occupational asthma.

Induced Sputum

Induced sputum analysis can demonstrate eosinophilia exceeding 3%, which supports the presence of eosinophilic airway inflammation. Serial sputum analyses performed during work exposure and during periods away from work can demonstrate an increase in sputum eosinophils at work, providing additional evidence of work-related airway inflammation. This non-invasive technique serves as a useful adjunct to PEF monitoring and specific inhalation challenge.

FeNO

Fractional exhaled nitric oxide (FeNO) measurements reflect eosinophilic airway inflammation and can be used serially. Elevated FeNO levels during work exposure compared to levels measured during periods away from work support the diagnosis of occupational asthma. However, FeNO may be normal in non-eosinophilic forms of OA, including irritant-induced disease.

<image>A diagnostic algorithm for suspected occupational asthma. Starting box: "New-onset asthma or asthma worsening in relationship to work." Step 1: Detailed occupational and exposure history, smoking status, atopy assessment. Step 2: Confirm asthma diagnosis (spirometry with reversibility or methacholine challenge). Step 3: Establish work-relatedness: serial PEF monitoring (minimum 2 weeks at work, 2 weeks away), serial methacholine challenges, serial FeNO/sputum eosinophils. If positive: specific immunologic testing (SPT, sIgE for HMW agents). If inconclusive: specific inhalation challenge (SIC) - gold standard. Outcome branches: "Sensitizer-induced OA confirmed" (remove from exposure, notify occupational health), "Irritant-induced OA/RADS" (remove from irritant exposure), "Work-exacerbated asthma" (optimize asthma treatment, reduce exposure if possible). Side panel: legal/compensation considerations - document all findings meticulously for workers' compensation claims.</image>

Management

Removal from Exposure

Complete removal from the causative sensitizing agent is the most important therapeutic intervention and the most critical determinant of long-term prognosis. Complete avoidance of the specific sensitizer is the ideal outcome. When full removal is not possible, exposure reduction through engineering controls, improved ventilation, respiratory protection with appropriate respirators, and job modification within the same workplace may provide partial benefit, though it is important to recognize that respirators offer incomplete protection and may not prevent progressive sensitization. The economic and psychosocial consequences of job loss must be addressed through occupational rehabilitation resources, job retraining programs, and workers' compensation advocacy.

Pharmacotherapy

Pharmacologic management of occupational asthma follows the same stepwise approach used for non-occupational asthma, incorporating inhaled corticosteroids, long-acting beta-agonists, long-acting muscarinic antagonists, and biologic agents as indicated by disease severity. However, medications are adjunctive to exposure avoidance and are not a substitute for it. Continuing to work in an environment with ongoing sensitizer exposure while relying on pharmacotherapy alone is insufficient and allows disease progression. Many patients retain persistent bronchial hyperresponsiveness and chronic asthma symptoms even years after complete removal from the causative exposure.

Prognosis After Removal

Approximately 30 to 50% of occupational asthma patients have persistent symptoms and bronchial hyperresponsiveness even years after complete removal from the causative exposure. Predictors of poor outcome include longer duration of symptomatic exposure before diagnosis (underscoring the critical importance of early recognition), greater disease severity at the time of diagnosis, and exposure to LMW agents, particularly isocyanates. These prognostic data emphasize that the window of opportunity for optimal outcomes is narrow, and that delays in diagnosis and removal carry permanent consequences.

Occupational Rhinitis

Occupational rhinitis is frequently the harbinger of occupational asthma, preceding lower airway disease by one to three years in many cases. The same agents that cause occupational asthma are responsible for occupational rhinitis. Diagnosis can be supported by nasal provocation testing (in research settings), serial nasal peak flow measurements, and specific IgE testing. All workers presenting with occupational rhinitis should be systematically screened for asthma with spirometry and methacholine challenge testing, as this represents an opportunity for early detection and intervention before irreversible airway changes develop.

Latex Allergy (Historical and Ongoing)

Natural rubber latex, derived from the rubber tree Hevea brasiliensis, contains more than 15 identified allergenic proteins designated Hev b 1 through Hev b 15. Although the prevalence of latex allergy has decreased dramatically with the widespread transition to non-latex gloves and the 2017 FDA ban on powdered latex gloves (which aerosolized latex allergens), it remains a relevant clinical entity. IgE-mediated latex allergy manifests as contact urticaria, angioedema, rhinoconjunctivitis, asthma, and, in severe cases, anaphylaxis. High-risk groups include healthcare workers, rubber industry workers, and patients with spina bifida or urogenital anomalies who have undergone repeated latex-containing surgical procedures.

The latex-fruit syndrome represents a clinically important cross-reactivity between latex allergens and proteins found in banana, avocado, kiwi, and chestnut. This cross-reactivity is mediated by class I chitinases containing a hevein-like domain that shares structural homology with the major latex allergen Hev b 6.02. Diagnosis relies on skin prick testing with latex extract and measurement of serum-specific IgE, with component testing for Hev b 5 and Hev b 6.02 providing additional diagnostic refinement. Prevention centers on establishing latex-free environments in healthcare settings.

Key Clinical Pearls

• Occupational asthma accounts for 15-25% of adult-onset asthma; always ask about occupational exposures in new adult asthma presentations
• The diagnosis of occupational asthma requires demonstrating a temporal relationship between workplace exposure and asthma symptoms/physiology (not just sensitization)
• Serial PEF monitoring (OASYS analysis) is the most practical and validated tool for establishing work-relatedness
• Specific inhalation challenge is the gold standard but available only in specialized centers
• Early removal from exposure is critical: delayed diagnosis leads to persistent asthma in 30-50% of patients even after removal
• Negative specific IgE for isocyanates does NOT exclude isocyanate-induced OA (sensitivity only 20-50%)
• Occupational rhinitis often precedes OA by 1-3 years; screen for asthma in all workers with occupational rhinitis
• RADS (irritant-induced OA) requires NO latency period; a single high-level irritant exposure can cause persistent asthma

References

1. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370(7):640-649.
2. Malo JL, et al. An official ATS technical standard: serial peak expiratory flow monitoring for the diagnosis of occupational asthma. Am J Respir Crit Care Med. 2015;193(12):e47-e67.
3. Vandenplas O, et al. EAACI position paper: irritant-induced asthma. Allergy. 2014;69(9):1141-1153.
4. Fishwick D, et al. Occupational asthma. Eur Respir Rev. 2020;29(156):190064.
5. Quirce S, et al. Occupational asthma: current diagnostic and management approaches. J Allergy Clin Immunol Pract. 2015;3(1):9-17.

Read this lecture as Markdown